Catalyst Wire Dossier Catalyst Wire Dossier

TAZAROTENE

TAZAROTENE · Padagis Israel Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for TAZAROTENE, covering 2012-05-11 to 2025-03-10. Get the full timeline:

Most recent: FDA Approved: TAZAROTENE — Supplemental Application (Mayne Pharma)

See pricing